First Time Loading...
I

IX Biopharma Ltd
SGX:42C

Watchlist Manager
IX Biopharma Ltd
SGX:42C
Watchlist
Price: 0.043 SGD -10.42% Market Closed
Updated: May 8, 2024

IX Biopharma Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IX Biopharma Ltd
Revenue Peer Comparison

Comparables:
WVE
H02
H
1J5

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
IX Biopharma Ltd
SGX:42C
Revenue
S$6.1m
CAGR 3-Years
59%
CAGR 5-Years
75%
CAGR 10-Years
N/A
WAVE Life Sciences Ltd
NASDAQ:WVE
Revenue
$113.3m
CAGR 3-Years
78%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Haw Par Corporation Ltd
SGX:H02
Revenue
S$232.1m
CAGR 3-Years
28%
CAGR 5-Years
0%
CAGR 10-Years
5%
H
Hyphens Pharma International Ltd
SGX:1J5
Revenue
S$170.6m
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is IX Biopharma Ltd's Revenue?
Revenue
6.1m SGD

Based on the financial report for Dec 31, 2023, IX Biopharma Ltd's Revenue amounts to 6.1m SGD.

What is IX Biopharma Ltd's Revenue growth rate?
Revenue CAGR 5Y
75%

Over the last year, the Revenue growth was 62%. The average annual Revenue growth rates for IX Biopharma Ltd have been 59% over the past three years , 75% over the past five years .